GLP-1 medications are some of the most significant advances in weight care in decades. Drugs like semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) have helped people in clinical trials lose 15–20% of their body weight on average. That is a level of results that once required surgery.
So what exactly is a GLP-1, and why do these medications work so well? Here is a plain-language guide.
GLP-1 is a hormone your body already makes
GLP-1 stands for glucagon-like peptide-1. It is a hormone released by cells in your intestine after you eat. It acts as a messenger between your gut, your pancreas and your brain, and it does several things at once:
- Signals fullness. GLP-1 acts on appetite centers in the brain, helping you feel satisfied sooner and reducing hunger between meals.
- Slows digestion. It slows how quickly food leaves your stomach, so you stay full for longer.
- Helps regulate blood sugar. It prompts the pancreas to release insulin when blood sugar rises, and it lowers glucagon, a hormone that raises blood sugar.
The catch is that natural GLP-1 breaks down within a couple of minutes. Your body clears it almost as quickly as it makes it.
How GLP-1 medications are different
GLP-1 medications are called GLP-1 receptor agonists. They mimic your natural hormone but are engineered to last much longer, which is why many are taken as a once-weekly injection. Because the signal stays on, the effects on appetite, fullness and blood sugar are much stronger and steadier than what your body produces on its own.
The most common options today:
| Medication | Brand names | How it works |
|---|---|---|
| Semaglutide | Wegovy (weight), Ozempic (type 2 diabetes) | GLP-1 receptor agonist |
| Tirzepatide | Zepbound (weight), Mounjaro (type 2 diabetes) | Dual GIP and GLP-1 receptor agonist |
| Liraglutide | Saxenda (weight), Victoza (type 2 diabetes) | GLP-1 receptor agonist, taken daily |
Tirzepatide also activates the receptor for GIP, a second gut hormone. This dual action is one reason it has produced larger average weight loss in trials.
What the research shows
GLP-1 medications have been studied in large, randomized controlled trials:
- Semaglutide (STEP 1): Adults with overweight or obesity taking semaglutide 2.4 mg weekly lost an average of 14.9% of their body weight over 68 weeks, compared with 2.4% on placebo. Both groups also received lifestyle support.
- Tirzepatide (SURMOUNT-1): Adults on the highest dose lost an average of 20.9% of their body weight over 72 weeks, compared with 3.1% on placebo.
- Heart health (SELECT): In people with existing cardiovascular disease and overweight or obesity, but without diabetes, semaglutide reduced the risk of major cardiovascular events such as heart attack and stroke by 20%.
These are averages. Some people lose more, some lose less, and results depend on dose, consistency, and the habits built alongside treatment.
Common side effects
Most side effects are digestive and happen most often while the dose is being increased:
- Nausea
- Diarrhea or constipation
- Vomiting
- Reduced appetite, sometimes more than expected
- Heartburn or bloating
This is why GLP-1 treatment usually starts at a low dose and increases gradually over several months. Eating smaller meals, slowing down, staying hydrated, and limiting very fatty or greasy foods can help.
Less common but more serious risks include pancreatitis, gallbladder problems, and low blood sugar in people who also take insulin or sulfonylureas. GLP-1 medications carry a warning about thyroid C-cell tumors seen in rodent studies. They are not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). They should not be used during pregnancy.
Who GLP-1 medications are for
FDA-approved GLP-1 medications for chronic weight management are generally prescribed for adults with:
- A BMI of 30 or higher, or
- A BMI of 27 or higher plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, high cholesterol or sleep apnea.
A licensed clinician should review your health history, current medications and goals before prescribing. GLP-1s work best as part of a broader plan that includes nutrition, protein intake, strength training and sleep.
What happens if you stop?
Obesity is a chronic condition, and GLP-1 medications treat it while you take them. In a follow-up to the STEP 1 trial, people who stopped semaglutide regained about two-thirds of the weight they had lost within a year. Many people stay on treatment long-term. Others work with their clinician on a plan to taper off while keeping the habits they built. Either way, the decision is one to make with your provider.
The bottom line
GLP-1 medications work with your body's own fullness and blood-sugar signals, and they make that signal stronger and longer-lasting. For the right person, under medical supervision, they can be a powerful tool for lasting weight loss and better metabolic health.
This article is for educational purposes only and is not a substitute for medical advice. Talk to a licensed clinician about whether a GLP-1 medication is right for you.
